Sign in to confirm you’re not a bot
This helps protect our community. Learn more
Comments are turned off. Learn more

OHA Director Pat Allen

2:54

Wendy Watson, COO, Kaiser

12:52

Dr. Mary Giswald, Kaiser

17:20

Dan Herman, CEO, 211info

19:44

Stephen Certo, Safeway/Albertsons

23:11

Dr. Dean Sidelinger

26:45

Can you provide any more details about the breakthrough cases?

33:18

Are the breakthrough cases in Lane and Yamhill Counties related?

35:33

Can you talk about what sorts of genomic surveillance you are doing around these breakthrough cases?

37:14

Has the presence of the South African variant in California raised any concerns?

38:01

Could you go into more detail about how vaccine doses are being allocated to smaller pharmacies and the equity issue related to that?

39:45

Could you speak to any changes in testing protocols or infrastructure to test for variants and what plans are in place to prepare for that?

41:56

Is there anywhere people can access a list of available pharmacies?

44:45

What about non web accessible folks?

45:36

Talk a bit more about reaching community immunity and what point we might reach that?

46:52

What is the status of getting vaccinations for younger people?

50:42

Can you describe how common breakthrough cases are?

51:51

What would you say to the CDC recommendation about people who have been vaccinated not needing to quarantine?

54:04
OHA COVID-19 Media Availability, Feb. 12, 2021
1Likes
974Views
2021Feb 12
Timestamps 2:54 OHA Director Pat Allen 12:52 Wendy Watson, COO, Kaiser 17:20 Dr. Mary Giswald, Kaiser 19:44 Dan Herman, CEO, 211info 23:11 Stephen Certo, Safeway/Albertsons 26:45 Dr. Dean Sidelinger Questions: 33:18 Can you provide any more details about the breakthrough cases? 35:33 Are the breakthrough cases in Lane and Yamhill Counties related? 37:14 Can you talk about what sorts of genomic surveillance you are doing around these breakthrough cases? 38:01 Has the presence of the South African variant in California raised any concerns? 39:45 Could you go into more detail about how vaccine doses are being allocated to smaller pharmacies and the equity issue related to that? 41:56 Could you speak to any changes in testing protocols or infrastructure to test for variants and what plans are in place to prepare for that? 44:45 Is there anywhere people can access a list of available pharmacies? 45:36 What about non web accessible folks? 46:52 Talk a bit more about reaching community immunity and what point we might reach that? 50:42 What is the status of getting vaccinations for younger people? 51:51 Can you describe how common breakthrough cases are? 54:04 What would you say to the CDC recommendation about people who have been vaccinated not needing to quarantine?

Follow along using the transcript.

Oregon Health Authority

9.3K subscribers